Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 7, 2006
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
281/14/9418    most recent
M513580200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wewer, U. M.
Right arrow Articles by Albrechtsen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wewer, U. M.
Right arrow Articles by Albrechtsen, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print February 2, 2006
J. Biol. Chem, 10.1074/jbc.M513580200
Submitted on December 21, 2005
Revised on January 31, 2006
Accepted on February 2, 2006

ADAM12 is a four-leafed clover -the excised prodomain remains bound to the mature enzyme

Ulla M. Wewer, Matthias Mörgelin, Peter Holck, Jonas Jacobsen, Magnus C. Lydolph, Anders H. Johnsen, Marie Kveiborg, and Reidar Albrechtsen

Institute of Molecular Pathology, University of Copenhagen, Copenhagen 2100

Corresponding Author: ullaw{at}pai.ku.dk

The ADAMs (a disintegrin and metalloprotease) comprise a family of multidomain proteins with metalloprotease, cell adhesion, and signaling activities. Human ADAM12, which is implicated in disease such as cancer, is expressed in two splice forms, the transmembrane ADAM12-L and the shorter and soluble ADAM12-S. ADAM12 is synthesized as a zymogen with the prodomain keeping the metalloprotease inactive through a cysteine-switch mechanism. Maturation and activation of the protease involves the cleavage of the prodomain in the trans-Golgi or possibly at the cell surface by a furin-peptidase. The aim of the present study was to determine the fate of the prodomain following furin cleavage. Here we demonstrate that, following cleavage of the human ADAM12-S prodomain in the trans-Golgi by a furin-peptidase, the prodomain remains non-covalently associated with the mature molecule. Accordingly, both the 68 kDa mature form of ADAM12-S and the 25 kDa prodomain could be detected using domain-specific antisera in immuno-precipitation and Western blot analyses of human serum ADAM12 and purified recombinant human ADAM12. Using EM negative staining we have furthermore obtained the first visualization of a full-length ADAM molecule, human ADAM12-S, and report that it appears to be a compact clover composed of four globular domains, one of which is the prodomain. Finally, our data demonstrate that the presence of the metalloprotease domain appears to be sufficient for the prodomain to remain associated with the mature ADAM12-S. Thus, we conclude that the prodomain of human ADAM12-S is an integral domain of the mature molecule and as such might have specific biological functions in the extracellular space.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. P. Sorensen, R. R. Vives, C. Manetopoulos, R. Albrechtsen, M. C. Lydolph, J. Jacobsen, J. R. Couchman, and U. M. Wewer
Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism
J. Biol. Chem., November 14, 2008; 283(46): 31920 - 31932.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Bourd-Boittin, H. Le Pabic, D. Bonnier, A. L'Helgoualc'h, and N. Theret
RACK1, a New ADAM12 Interacting Protein: CONTRIBUTION TO LIVER FIBROGENESIS
J. Biol. Chem., September 19, 2008; 283(38): 26000 - 26009.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Golubkov, A. V. Chekanov, S. A. Shiryaev, A. E. Aleshin, B. I. Ratnikov, K. Gawlik, I. Radichev, K. Motamedchaboki, J. W. Smith, and A. Y. Strongin
Proteolysis of the Membrane Type-1 Matrix Metalloproteinase Prodomain: IMPLICATIONS FOR A TWO-STEP PROTEOLYTIC PROCESSING AND ACTIVATION
J. Biol. Chem., December 14, 2007; 282(50): 36283 - 36291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-H. Koo, J.-M. Longpre, R. P. T. Somerville, J. P. Alexander, R. Leduc, and S. S. Apte
Regulation of ADAMTS9 Secretion and Enzymatic Activity by Its Propeptide
J. Biol. Chem., June 1, 2007; 282(22): 16146 - 16154.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Frohlich, R. Albrechtsen, L. Dyrskjot, L. Rudkjaer, T. F. Orntoft, and U. M. Wewer
Molecular Profiling of ADAM12 in Human Bladder Cancer
Clin. Cancer Res., December 15, 2006; 12(24): 7359 - 7368.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement